These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2136916

  • 1. Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
    Murphy RA, Kung HF, Kung MP, Billings J.
    J Med Chem; 1990 Jan; 33(1):171-8. PubMed ID: 2136916
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
    Kung HF, Kasliwal R, Pan SG, Kung MP, Mach RH, Guo YZ.
    J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
    [Abstract] [Full Text] [Related]

  • 3. The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.
    Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A.
    J Nucl Med; 1990 May; 31(5):648-54. PubMed ID: 2140409
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF, Pan S, Kung MP, Billings J, Kasliwal R, Reilley J, Alavi A.
    J Nucl Med; 1989 Jan; 30(1):88-92. PubMed ID: 2783457
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP, Bobeldijk M, Feenstra MG, Boer GJ, Maas MA, Erdtsieck-Ernste E, de Bruin K, van Royen EA.
    Int J Rad Appl Instrum B; 1991 Jan; 18(8):837-46. PubMed ID: 1839302
    [Abstract] [Full Text] [Related]

  • 6. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors.
    Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D.
    Life Sci; 1991 Jan; 49(8):617-28. PubMed ID: 1830917
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and resolution of (+-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro- 1H-3- benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptor.
    Chumpradit S, Kung MP, Billings JJ, Kung HF.
    J Med Chem; 1991 Mar; 34(3):877-83. PubMed ID: 1825848
    [Abstract] [Full Text] [Related]

  • 8. Preparation and biodistribution of [125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
    Kung HF, Guo YZ, Billings J, Xu X, Mach RH, Blau M, Ackerhalt RE.
    Int J Rad Appl Instrum B; 1988 Mar; 15(2):195-201. PubMed ID: 2966782
    [Abstract] [Full Text] [Related]

  • 9. In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
    Brücke T, Tsai YF, McLellan C, Singhanyom W, Kung HF, Cohen RM, Chiueh CC.
    Life Sci; 1988 Mar; 42(21):2097-104. PubMed ID: 3260318
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
    Saji H, Tanahashi K, Kinoshita T, Iida Y, Magata Y, Yokoyama A.
    Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
    [Abstract] [Full Text] [Related]

  • 11. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
    Schonwetter BS, Luedtke RR, Kung MP, Billings J, Kung HF, Molinoff PB.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):110-6. PubMed ID: 2526213
    [Abstract] [Full Text] [Related]

  • 12. (+/-)-7-chloro-8-hydroxy-1-(4'-[125I]iodophenyl)-3-methyl-2,3,4,5- tetrahydro-1H-3-benzazepine: a potential CNS D-1 dopamine receptor imaging agent.
    Chumpradit S, Kung HF, Billings J, Kung MP, Pan S.
    J Med Chem; 1989 Jul; 32(7):1431-5. PubMed ID: 2525621
    [Abstract] [Full Text] [Related]

  • 13. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ, Kung MP, Chumpradit S, Mozley D, Alavi A, Kung HF.
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [Abstract] [Full Text] [Related]

  • 14. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T, Ström P, de Paulis T, Stensland B, Csöregh I, Lundin K, Hall H, Ogren SO.
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [Abstract] [Full Text] [Related]

  • 15. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB, Malison RT, al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO.
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [Abstract] [Full Text] [Related]

  • 16. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T, de Paulis T, Johansson L, Kumar Y, Hall H, Ogren SO.
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2'-ISP in nonhuman primates.
    Baldwin RM, Zea-Ponce Y, Zoghbi SS, al-Tikriti MS, Seibyl JP, Sybirska EH, Malison RT, Laruelle M, Charney DS, Hoffer PB.
    Nucl Med Biol; 1994 Oct; 21(7):969-76. PubMed ID: 9234352
    [Abstract] [Full Text] [Related]

  • 18. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL, Largent BL, Snyder SH.
    Life Sci; 1984 Nov 05; 35(19):1981-8. PubMed ID: 6149442
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 20. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
    de Paulis T, Janowsky A, Kessler RM, Clanton JA, Smith HE.
    J Med Chem; 1988 Oct 16; 31(10):2027-33. PubMed ID: 3172140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.